Skip to main content

#156633

Anti-Myosin (MYH2) [N2.261]

Cat. #156633

Anti-Myosin (MYH2) [N2.261]

Cat. #: 156633

Unit size: 100 ug

Availability: 10-12 weeks

Target: MYH7 and MYH2

Class: Monoclonal

Application: IHC ; WB

Reactivity: Human ; Mouse ; Rabbit ; FIsh

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: Medical Research Council ; Stanford University

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-Myosin (MYH2) [N2.261]
  • Alternate name: Beta slow cardiac myosin heavy chain and skeletal myosin heavy chain type IIA
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 220000
  • Reactivity: Human ; Mouse ; Rabbit ; FIsh
  • Host: Mouse
  • Application: IHC ; WB
  • Description: Recognises the N-terminal part (S1) of beta slow myosin heavy chain (MYH7) in neonate and adult and adult skeletal myosin heavy chain type IIA (MYH2).
  • Immunogen: Purified neonatal human skeletal muscle myosin.
  • Recommended controls: IgG1

Target Details

  • Target: MYH7 and MYH2
  • Molecular weight: 220000
  • Target background: Recognises the N-terminal part (S1) of beta slow myosin heavy chain (MYH7) in neonate and adult and adult skeletal myosin heavy chain type IIA (MYH2).

Applications

  • Application: IHC ; WB

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Dry ice

References

  • Hughes et al. 1993. Dev Biol. 158(1):183-99. PMID: 7687223.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.